SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-15-220689
Filing Date
2015-06-11
Accepted
2015-06-11 17:00:52
Documents
2
Effectiveness Date
2015-06-11

Document Format Files

Seq Description Document Type Size
1 DEFA14A d941610ddefa14a.htm DEFA14A 18283
2 GRAPHIC g9416101.jpg GRAPHIC 9635
  Complete submission text file 0001193125-15-220689.txt   32910
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-22873 | Film No.: 15926613
SIC: 2835 In Vitro & In Vivo Diagnostic Substances